Sentinel Lymph Node Biopsy vs Lymphadenectomy: New Standard for Cervical Cancer Treatment скачать в хорошем качестве

Sentinel Lymph Node Biopsy vs Lymphadenectomy: New Standard for Cervical Cancer Treatment

Sentinel lymph node biopsy cervical cancer lymphadenectomy early-stage cervical cancer disease-free survival cancer treatment NEJM study Discover the latest breakthrough in cervical cancer treatment. A groundbreaking study published in the New England Journal of Medicine shows that sentinel lymph node biopsy alone is noninferior to full lymphadenectomy for patients with early-stage cervical cancer. Key findings include: Three-year disease-free survival rates: 96.9% for biopsy-only vs. 94.6% for lymphadenectomy. Fewer complications like lymphocyst, lymphedema, and pain in the biopsy-only group. No retroperitoneal nodal recurrences in the biopsy-only group. This multicenter randomized trial involved over 800 patients and suggests sentinel lymph node biopsy as the new standard for surgical management. Learn about the implications for patients, benefits of less invasive procedures, and how this could change cervical cancer care worldwide. Stay informed on medical advancements in oncology.